Idexx Laboratories Inc (IDXX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats.
The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including: - Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights Idexx Laboratories Inc (IDEXX) is a company with focus on enhancing the health and well-being of pets, people, and livestock.It develops, manufactures, and distributes products and provides services for the companion animal, veterinary, livestock and poultry, dairy and water testing markets.
The company offers point-of-care veterinary diagnostic products, microbiological contaminant testing products (in water), livestock and poultry diagnostic and health-monitoring products, antibiotic residue testing products (in milk), veterinary reference laboratory diagnostics and consulting services and practice management systems and services.IDEXX also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.
It operates along with its subsidiaries in the Americas, Europe, the Middle East, Africa and Asia-Pacific. IDEXX is headquartered in Westbrook, Maine, the US.
Idexx Laboratories Inc Key Recent Developments May 04,2018: IDEXX Laboratories Announces First Quarter Results 2018 Feb 01,2018: IDEXX Laboratories Announces Fourth Quarter and Full Year 2017 Results Jan 08,2018: IDEXX to Introduce Applied BioCode’s Innovative Multiplex Technology across Global Reference Laboratory Network Oct 31,2017: IDEXX Laboratories Announces Third Quarter Results Jul 17,2017: IDEXX Laboratories Elects Stuart M. Essig to Board of Directors
Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
North America cancer screening market North America is leading the cancer screening market. The region is technologically equipped and being a developed economy it is efficiently catering to the rising incidence of cancer cases. The market is forecasted to grow at a compound annual growth rate (CAGR) f 11.14% resulting in an annual...
This report provides a worldwide overview of the infectious disease testing market environment, structure, size and growth. Includes estimates of the number of laboratories performing infectious disease tests, as well as ten-year test volume and sales forecasts by country.Contains 15 pages and 3 tables
This report provides estimates of the number of laboratories performing tumor marker assays, as well as test volume and sales forecasts by country.The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution...
KEY FINDINGS The global laboratory filtration market is expected to grow with a CAGR of 6.87% during the forecasted period 2019-2027. Laboratory filtration helps in removal of pollutants such as fine sediment particulates and phosphorus & nitrogen particulate species. These media filters are also used for industrial, commercial...
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country.Contains 11 pages and 3 tables
This new 148-page report from VPGMarketResearch.com reviews current instrumentation technologies, and profiles features of leading automated and semi-automated Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic analyzers. The report also presents strategic assessments...
This report provides a worldwide overview of the transfusion testing market, including estimates of facilities performing transfusion testing tests, as well as test volume, reagent and instrument sales forecasts for blood typing, grouping and infectious disease screening tests by country.Contains 15 pages and 5 tables
Asia-Pacific cancer screening market Asia-Pacific is a rapidly growing cancer market. The market is forecasted to grow at a compound annual growth rate (CAGR) of 17.3% resulting in annual revenue of USD 32.26 Bn during the forecast period (2018-2023). Asia Pacific is rapidly adopting the latest technological developments and is contributing...
Europe cancer screening market Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along...
Latin America cancer screening market The Latin America cancer screening market is currently valued at USD 21.24 billion and is forecasted to achieve a growth rate of 7.19 % compound annual growth rate (CAGR) leading to a regional revenue of USD 30.06 Bn. Latin America’s growth is much slower compared to other regions. The region needs...